Amgen (AMGN)

R&D Expense Growth

16.93%

Fiscal year · Period ending:

AMGN logo

AMGN R&D Expense Growth

Latest reported16.93%
AMGN FY R&D Growth (YoY) (0.00% → 16.93%)
High-resolution chart · PNG

AMGN r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
16.9349%
24.6656%
7.8935%
-29.8861%
50.3209%
2.2109%
10.1418%
4.913%
-7.2396%
-5.6511%
-5.2828%
5.2412%
20.7988%
6.7256%
9.4333%
1.0475%
-5.4785%
-7.226%
-2.9709%
45.4624%
14.1026%
22.5378%
48.1647%
29.1329%
2.3669%
2.6981%
24.0464%
5.1522%
19.4019%
16.9582%
39.5859%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.